ESPACOMP Medication Adherence Reporting Guideline (EMERGE)
- PMID: 29946690
- PMCID: PMC7643841
- DOI: 10.7326/M18-0543
ESPACOMP Medication Adherence Reporting Guideline (EMERGE)
Abstract
Research on assessing or managing medication adherence applies approaches from observational, interventional, and implementation science that spans many disciplines and demands coherent conceptualization, valid methods, appropriate analyses, and complete and accurate reporting. To ensure such reporting, the European Society for Patient Adherence, COMpliance, and Persistence (ESPACOMP) Medication Adherence Reporting Guideline (EMERGE) recommends standard reporting approaches based on an accepted taxonomy. This guideline is derived from a literature review, a reactive Delphi study with 26 medication adherence experts from many countries and disciplines, and feedback from ESPACOMP members. It is designed to supplement existing guidelines for health research reporting and is structured around 4 minimum reporting criteria and 17 items reflecting best reporting practice. By enhancing and harmonizing research reporting, EMERGE aims to advance research and, ultimately, patient outcomes.
Conflict of interest statement
Declaration of conflicting interests
The authors have no conflicts of interest to disclose.
References
-
- De Geest S and Ruppar T. Virtual special issue: Medication adherence. 2015. https://journals.sagepub.com/page/cnu/collections/virtual-special-issues...
-
- Senft Y, Kirsch M, Denhaerynck K, et al. Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study. Eur J Cardiovasc Nurs 2018; 17: 356–367. Epub ahead of print 12 December 2017. DOI: 10.1177/1474515117747577. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources